Putrescine administration reduces the rate of DNA synthesis in Ehrlich ascites tumor cells in vivo.
D000818:Animals; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D008297:Male; D051379:Mice; D008940:Mitotic Index / Q000187:drug effects; D009368:Neoplasm Transplantation; D009955:Ornithine Decarboxylase / Q000378:metabolism; D065108:Ornithine Decarboxylase Inhibitors; D011700:Putrescine / Q000494:pharmacology*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D065108:Ornithine Decarboxylase Inhibitors; D009955:Ornithine Decarboxylase; D011700:Putrescine